Your weekly roundup of the latest news from Drug Topics®.
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists (ASHP), sat down with Drug Topics to discuss the current drug shortages and how pharmacists are dealing with them.
Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.
The Vice President of Industry Relations at IQVIA gave a presentation at the 2023 PBMI Annual National Conference in Orlando, where he discussed everything from healthcare utilization during COVID-19 to spending on specialty drugs.
The clinical pharmacist will play an important role as a medication expert, filling in for the role that pharmaceutical manufacturers once did in supporting patients and prescribers.
Sampson Davis, MD, the keynote speaker for the 2023 PBMI Annual National Conference, discussed how the health care system needs to build trust and tailor approaches that meet community needs.
Driving Primary Vendor Compliance to Increase Pharmacy Purchasing Savings
April 17th 2025This white paper will examine some common—and costly—assumptions about vendor compliance. We’ll show that pharmacies must do more than meet the bare minimum to stay competitive. We’ll also discuss solutions that pharmacies can leverage to optimize compliance, drive savings from their primary vendor, unlock additional pharmacy savings and enhance purchasing.